Podcasts about 3d bioprinting

In the new science fiction film Mickey 17, Robert Pattinson’s character Mickey Barnes is killed and each time he dies, a new copy of his body is printed out. It’s a classic far-flung sci-fi premise -- but the technology it’s based on is far more science than fiction. 3D bioprinting is a technology that uses 3D printing to create tissues and organs from living cells and biomaterials. The technology has been evolving rapidly over the last couple of decades. So how far away are we from printing out multiple Robert Pattinsons? Today on The Front Page, University of Queensland’s Professor Sašo Ivanovski joins us to break down 3D Bioprinting, where the technology is at, and what its future looks like. Follow The Front Page on iHeartRadio, Apple Podcasts, Spotify or wherever you get your podcasts. You can read more about this and other stories in the New Zealand Herald, online at nzherald.co.nz, or tune in to news bulletins across the NZME network. Host: Chelsea DanielsSound Engineer/Producer: Richard MartinProducer: Ethan SillsSee omnystudio.com/listener for privacy information.

February is American Heart Month, and in light of that, we're bringing back an episode about a group here at Stanford Engineering that's developing 3D printing methods for human tissues and organs, a process known as bioprinting. Motivated in part by the critical need for heart transplants, Mark Skylar-Scott and his team are specifically working to bioprint tissues of the human heart. It may sound like science fiction, but it's actually just another example of the groundbreaking research we do here. We hope you'll take another listen and be inspired by the possibilities.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Mark A. Skylar-ScottMark's Lab: The Skylar-Scott Lab | Stanford MedicineConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Mark Skylar-Scott, a professor of bioengineering at Stanford University.(00:02:06) What is Bioprinting?The role of cells and biopolymers in printing functional biological structures.(00:03:31) Bioprinting a HeartThe potential of printing organs on demand, especially heart tissue.(00:04:38) Obtaining Cells for BioprintingUsing stem cells derived from the patient's own cells to create heart tissue.(00:06:29) Creating Multiple Cell Types for the HeartThe challenge of printing eleven different heart cell types with precision.(00:08:50) The Scaffold for 3D PrintingThe support material used in 3D printing and how it's later removed.(00:10:10) Cell Migration and Organ FormationHow cells organize themselves to form functional heart tissue.(00:12:08) Growing a Full-Sized HeartWhether they're printing full-sized hearts or starting with smaller organs.(00:13:34) Avoiding Overgrowth RisksThe role of bioreactors in shaping the early stages of the organ.(00:14:57) Scaling Up Cell ProductionThe need to generate massive numbers of cells for experimentation.(00:18:32) The Challenge of VascularizationCreating a blood vessel network to supply oxygen and nutrients.(00:22:35) Ethical Considerations in BioprintingConsent, stem cell sourcing, and the broader ethical landscape.(00:26:04) The Timeline for Bioprinted OrgansThe long timeline for bioprinted organs to reach clinical use.(00:27:24) The State of the Field & CollaborationThe collaborative, competitive biofabrication field and its rapid progress.(00:28:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

The Italian Institute of Technology (IIT) is returning to Maker Faire Rome with an impressive array of cutting-edge technologies, developed through research at their 16 centres across Italy. These innovations are designed to improve everyday life and ensure personal and infrastructural safety, offering an exciting glimpse of what visitors can experience from October 25th to 27th at the Gazometro Ostiense. Maker Faire Rome returns Rehabilitation Exoskeletons Making its debut at Maker Faire Rome, FloatEVO will be unveiled at the INAIL Central Research Directorate booth the 25 th of October. Developed by Rehab Technologies IIT-INAIL, a joint lab between IIT and INAIL, FloatEVO is the next generation of the previous FLOAT model, co-created with the INAIL Motor Rehabilitation Centre in Volterra. This wearable robotic medical device for upper limbs features an innovative flipping mechanism that allows it to be used for the rehabilitation of both the left and right arms. Designed to accelerate recovery for shoulder and elbow injuries, FloatEVO is aimed at patients recovering from trauma-induced orthopedic or neurological injuries. TWIN At the same booth, you can also explore Twin, a lower-limb robotic exoskeleton designed for medical applications and rehabilitation therapies. Twin is a game-changer for individuals with limited or no mobility in their lower limbs, helping them to stand, walk with crutches or walkers, and even sit and stand up again. This exoskeleton was co-developed with the INAIL Prosthetic Centre in Budrio by the Rehab Technologies team at IIT-INAIL. IIT Softbots On display at another stand will be the latest robotic and prosthetic innovations developed by the IIT Soft Robotics for Human Cooperation and Rehabilitation unit, in collaboration with the E. Piaggio Centre at the University of Pisa. Among the standout projects is AlterEgo, a humanoid robot designed for remote assistance in hazardous environments. Equipped with robotic hands, AlterEgo can interact with its surroundings and is controlled through wearable sensors and VR headsets. Also featured is SoftHand Pro, a flexible prosthetic hand with 19 joints, offering intuitive grip and control, along with SoftFoot Pro, an advanced prosthetic foot inspired by human anatomy. SoftFoot Pro is engineered to adapt to uneven surfaces, providing stability and comfort for everyday use. 3D Bioprinting of Human Tissues 3D bioprinting is one of the most exciting technologies in regenerative medicine and pathology research. IIT's Nanotechnologies for Neurosciences unit, part of the Center for Life Nano- and Neuroscience in Rome, will demonstrate 3D bioprinting techniques capable of replicating specific human tissues. Visitors will have the chance to witness live 3D printing of cells and interact with the freshly printed objects. This hands-on experience is designed to engage younger visitors, allowing them to explore the world of biomaterials in a fun and educational way. Changing Bodies, Changing Minds Thanks to augmented virtual reality technologies developed by IIT's Neuroscience and Society unit, also from the Center for Life Nano- and Neuroscience in Rome, Maker Faire visitors will experience how adopting a virtual body can influence perception and behaviour. Through immersive VR scenarios, attendees will have the opportunity to step into the shoes of a famous world leader, deliver a speech in front of a virtual audience, compete in a dice game while their virtual body gradually disappears, or even experience the sensation of being touched as a different gender. RINGHIO Meet RINGHIO (Robot for Inspection and Navigation to Generate Heritage and Infrastructure Observations), a prototype created by the IIT's Industrial Robotics Unit in Genoa, together with the IIT's Centre for Cultural Heritage Technology in Venice, the Polytechnic University of Marche, and the University of Macerata. Initially designed to monitor Genoa's San Giorgio Bridge, in collaboration with several ...

The future of technology is poised to revolutionize every aspect of life with innovations that were once the realm of science fiction. Join Captain Hoff as he explores asteroid mining, 3D bioprinting, micro windmills, artificial wombs, mind readers, 5D nano storage, & more!

Dr. Judith Hagenbuchner ist seit 2017 Leiterin des 3D-Bioprinting-Labs. Das Labor zählte zu der damaligen Zeit zu den ersten, die es in Österreich gab.  Wie sooft im Leben, startet der Beginn des 3D-Bioprinting-Labs mit einer Idee, der Idee, Versuchstiere zu reduzieren.  Die Technik macht es möglich, denn mittels eines speziellen Druckers gelingt es, Zellen und Tumore herzustellen. Dreidimensional, reproduzierbar und tierversuchsfrei lautet hierbei die Devise.  Im Podcast-Interview spricht Judith Hagenbuchner mit Podcast-Host Robert Pacher über das 3D-Bioprinting-Lab, die Entwicklungen, Longevity und vieles mehr. ⬇️ **Dipl. Ing. Dr. Judith Hagenbuchner** Leiterin 3D-Bioprinting-Lab

(1:00) - Scientists 3D-print hair follicles in lab-grown skin

Biomotion Technologies aus Wien will das 3D-Bioprinting zugänglicher und reproduzierbarer machen. Dabei handelt es sich um eine dem 3D-Druck ähnliche Technologie, bei der biologisches Material wie Humanzellen zum Einsatz kommt. Die Bioprinter, die das Startup baut, sollen die „Reject Rate“ bei biologischen Geweben reduzieren. Damit spricht die Jungfirma vor allem Pharma-Unternehmen sowie Anbieter von 3D-gedruckten Geweben als Testsysteme an. Biomotion Technologies tritt am Mittwoch im Finale der #glaubandich Challenge an. Zu Gast im Podcast ist Gregor Weisgrab, Mitgründer und CEO der Jungfirma, die Themen: - Wie 3D-Bioprinting funktioniert - Die Einsatzbereiche von 3D-Bioprinting - Die Ziele, die sich Biomotion Technologies für das #glaubandich Finale setzt - Der Entwicklungsstand der Bioprinter der Jungfirma - Die Zukunft des 3D-Bioprinting E-Auto Polestar 2 jetzt im Leasing ab 283 Euro pro Monat Aktion abrufbar unter: ⁠www.polestar.com/at/polestar-2-2023⁠ Gültig bis 30.06.2023 Wenn dir diese Folge gefallen hat, lass uns doch vier, fünf Sterne als Bewertung da und folge dem Podcast auf Spotify, Apple Music und Co. Für Anregungen, Kritik, Feedback oder Wünsche zu künftigen Gästen schick uns jederzeit gerne eine Mail an feedback@trendingtopics.at.

As a mechanical engineer, Jin-Hyung Shim, Ph.D. has a unique perspective on tissue and organ regeneration. He discusses the present and potential of 3D printed biomaterials. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38321]

As a mechanical engineer, Jin-Hyung Shim, Ph.D. has a unique perspective on tissue and organ regeneration. He discusses the present and potential of 3D printed biomaterials. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38321]

As a mechanical engineer, Jin-Hyung Shim, Ph.D. has a unique perspective on tissue and organ regeneration. He discusses the present and potential of 3D printed biomaterials. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38321]

As a mechanical engineer, Jin-Hyung Shim, Ph.D. has a unique perspective on tissue and organ regeneration. He discusses the present and potential of 3D printed biomaterials. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38321]

As a mechanical engineer, Jin-Hyung Shim, Ph.D. has a unique perspective on tissue and organ regeneration. He discusses the present and potential of 3D printed biomaterials. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38321]

As a mechanical engineer, Jin-Hyung Shim, Ph.D. has a unique perspective on tissue and organ regeneration. He discusses the present and potential of 3D printed biomaterials. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38321]

THE SCIENCE OF 3D-BIOPRINTING IS REVOLUTIONIZING THE WAY TISSUES & ORGANS ARE DEVELOPED IN A LAB FOR IMPLANTATION IN PATIENTS. JOINING US IS TO DISCUSS IS THE MAN AT THE FOREFRONT OF THIS TECHNOLOGY (AND RETURNING GUEST), DR. ANTHONY ATALA, DIRECTOR OF THE WAKE FOREST INSTITUTE FOR REGENERATIVE MEDICINE.

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.11.13.516338v1?rss=1 Authors: Sullivan, M. A., Lane, S. D., Volkerling, A., Engel, M., Werry, E. L., Kassiou, M. Abstract: Current research tools for pre-clinical drug development such as rodent models and 2D immortalised monocultures have failed to serve as effective translational models for human CNS disorders. Recent advancements in the development of iPSCs and 3D culturing can improve the in vivo-relevance of pre-clinical models, while generating 3D cultures though novel bioprinting technologies can offer increased scalability and replicability. As such, there is a need to develop platforms that combine iPSC-derived cells with 3D bioprinting to produce scalable, tunable and biomimetic cultures for preclinical drug discovery applications. We report a biocompatible PEG-based matrix which incorporates RGD and YIGSR peptide motifs and full length collagen IV at a stiffness similar to the human brain (1.5 kPa). Using a high-throughput commercial bioprinter we report the viable culture and morphological development of iPSC-derived astrocytes, brain microvascular endothelial cells, neural progenitors and neurons in our novel matrix. We also show that this system supports endothelial vasculogenesis and enhances neural differentiation and spontaneous activity. This platform forms a foundation for more complex, multicellular models to facilitate high-throughput translational drug discovery for CNS disorders. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

You're going to learn about efforts to print astronaut skin in space with their own blood, the mystifying side effects of birth control, and the race to bring soil samples back from Mars!Blood skin.3D Bioprinting Artificial Bone for Emergency Medicine in Space by European Space Agencyhttps://scitechdaily.com/3d-bioprinting-artificial-bone-for-emergency-medicine-in-space/Upside-Down 3D-Printed Skin and Bone, for Humans to Mars by European Space Agencyhttps://www.esa.int/Enabling_Support/Space_Engineering_Technology/Upside-down_3D-printed_skin_and_bone_for_humans_to_MarsRegenerative Medicine and 3D Bioprinting for Human Space Exploration and Planet Colonization by Tommaso Ghidinihttps://dx.doi.org/10.21037%2Fjtd.2018.03.193D Bioprinting of Tissues and Organs by Sean V. Murphy & Anthony Atalahttps://doi.org/10.1038/nbt.2958Birth control plus extra.Why Birth Control Side Effects Have Eluded Science by Saima Sidikhttps://undark.org/2022/03/07/why-birth-control-side-effects-have-eluded-science/Oral Contraception and Serious Psychiatric Illness: Absence of an Association by M.P. Vessey, et al.https://doi.org/10.1192/bjp.146.1.45The Relationship Between Progestin Hormonal Contraception and Depression: A Systematic Review by Brett L. Worly, et al.https://doi.org/10.1016/j.contraception.2018.01.010Association of Hormonal Contraception With Depression by Charlotte Wessel Skovlund, et al.https://doi.org/10.1001/jamapsychiatry.2016.2387Hormonal Contraceptive Use is Associated with Neural and Affective Changes in Healthy Young Women by Nina Lisofsky, et al.https://doi.org/10.1016/j.neuroimage.2016.04.042Mars dirt.“China plans to return Mars samples to Earth in 2031: report” by Elizabeth Howellhttps://www.space.com/china-return-mars-samples-earth-2031“US military to keep wary eye on Chinese and Russian space ambitions under President Biden” by Mike Wallhttps://www.space.com/us-space-policy-china-russia-biden-administration“China aims to bring Mars samples to Earth 2 years before NASA, ESA mission” by Andrew Joneshttps://spacenews.com/china-aims-to-bring-mars-samples-to-earth-2-years-before-nasa-esa-mission/Follow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.Find episode transcripts here: https://curiosity-daily-4e53644e.simplecast.com/episodes/skin-print-testing-birth-control-race-to-bring-mars-home

Andrew Ridley, Ph.D., joins Hannah to discuss Cellink's achievement in winning the New Product Award at SLAS Europe 2022. Ridley explains what 3D bioprinting is and how BIO CELLX, the innovative biodispenser from Cellink, is shaping the future of drug discovery and tissue engineering. Also, Ridley shares a glimpse into what Cellink has in store for future products and how Cellink can provide to anyone wanting to use their technology without any tissue engineering experience.  To learn more about Cellink, visit: https://www.cellink.com/About Andrew Ridley, Ph.D.:Ridley is an experienced Product Manager/Sales Director with a Ph.D. focused in Molecular and Cellular Biology and has a history of working in the biotechnology industry. Skilled in molecular/cell biology with a focus on cutting-edge technologies including microfluidics and 3D bioprinting.Stay connected with SLAS:Online at www.slas.orgFacebookTwitter @SLAS_OrgLinkedInInstagram @slas_orgYouTubeAbout SLAS:SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.  For more information about SLAS, visit www.slas.org.SLAS publishes two peer-reviewed and MEDLINE-indexed scientific journals, SLAS Discovery and SLAS Technology. For more information about SLAS and its journals, visit www.slas.org/publications.Upcoming SLAS Events:SLAS 2022 Americas Sample Management SymposiumSeptember 15-16, 2022La Jolla, CA, USARegistration is now open for the 2022 AI Data Pipelines for Life Sciences Symposium in Seattle, WA, September 26-27.This two-day symposium will allow participants to explore how AI data pipelines are integrated into the life sciences. Attendees will learn about MLOPS, applications, techniques, and architectures of data and their uses in the life sciences. The SLAS 2022 Bio Entrepreneurship Symposium will allow emerging bio entrepreneurs, start-up companies, academics and those considering bio-entrepreneurship to explore the start-up ecosystem. Register by visiting: https://www.slas.org/events-calendar/slas-2022-bio-entrepreneurship-symposium/attend/register/

At the beginning of the year, I said I would follow my curiosity. One of the things I was curious about was 3D bioprinting. What does that even mean? I talked to Dr. Mohammad Albanna, CEO and founder of Humabiologics to learn more.Imagine creating 3D structures from living cells and a biological matrix. Then imagine depositing the materials for that structure with an injet printer. I promise, I didn’t get this watching Netflix.Dr. Albanna described for me the story of Dr. Tony Atala who grew a replacement bladder for a boy from that boy’s own cells back in 2001. And that boy, Luke Massella is now a grown man with a lab-grown bladder that is working to this day.Indeed, early experiments involved cleaning out injet cartridges, replacing the ink with biological materials and loading them into a printer.Now there are a handful of people with a bladder like Luke’s. Creating organs, though, is complicated. Kidneys, for example, have 20 different types of cells within them. They all have a job to do and they need to be in the right place in the right numbers to function. Similarly for a heart, or a liver, you need to get nutrients and oxygen in and waste out, not to mention assemble structures that can withstand the force of pumping blood.Transplantation is the exception. There are more immediate uses of 3D bioprinting. One is creating tissue models to better understand disease. Another is for testing drugs in development for both toxicity and efficacy. What if we could test a panel of drugs against a patient’s tumor to see which works best? Combined with genomic analysis, we might be able to find the right therapies faster (and probably learn a lot in the process).Listen to the full episode to learn more about the mechanics of 3D bioprinting, the need for allogeneic off the shelf materials and what Dr. Albanna sees for the future.Thank you for reading cc: Life Science. This post is public so feel free to share it. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com

Episodio 644, Live 75. Con Francesca Antonelli, Marco Casolino e Omar Serafini parleremo di stampanti 3D biologiche e delle potenzialità nel mondo della scienza e della fantascienza. Per l'immagine di copertina: © Aventi diritto. All rights reserved.Support this podcast at — https://redcircle.com/fantascienticast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Sergey Young is the Author of The Science of Growing Young, a new book about what future looks like for aging, and what we can do now to best improve our chances at living longer, healthier. Sergey is also a longevity investor and visionary with a mission to extend the healthy lifespans of 1 billion people. He is the Founder of the Longevity Vision Fund—one of the few funds specializing exclusively in longevity and helping to accelerate longevity breakthroughs and he is the Development Sponsor of Age Reversal XPRIZE, a global initiative designed to cure aging and age-related diseases. During our conversation, Sergey and I sync up about where his journey into longevity began, the inspiration behind his new book, which is all about longevity, extending our lifespan and healthspan, and the many futuristic and well not so futuristic methods on the horizon.  We also talk about what it means to “grow young” Sergey and I cover one of my favorite topics, DIY Health & At-Home Testing. We talk about some of the wearables, portables, embeddable, and ingestible's that help with early diagnosis of disease and why early diagnosis and detection of disease is paramount. Sergey offers ideas on how you can build your own dashboard health markers and get ahead of many diseases that could be avoided. We dive into the BioTech landscape and the innovations on the near and far horizon including Stem Cell Therapy, organ regeneration, 3D Bioprinting and how Human Genome Sequencing is paving the way for new technological advancements in healthcare. We also discuss some obstacles for these concepts to be adopted by mainstream consumers from health insurance and affordability, moral and ethical use of the technology/regulatory landscape and more. CONNECT Sergey Young on Instagram, Facebook, or LinkedIn Marni On The Move Instagram, Facebook, TikTok, LinkedIn, or YouTube Marni Salup on Instagram and Spotify SUBSCRIBE Sign up for our weekly newsletter, The Download for Marni on the Move updates, exclusive offers, invites to events, and exciting news! RIDE WITH ME  Meet me on Zwift, Strava, or Peloton OFFERS Take control of your health and wellness journey with InsideTracker, the ultra-personalized nutrition platform that analyzes your blood, DNA, and lifestyle to help you optimize your body from the inside out. Transform your body's data into meaningful insights and a customized action plan of the science-backed nutrition recommendations you need to optimize your health!  Get 25% percent off today at InsideTracker with our code CHEERSMARNI Head over to our SHOP page for additional offers from Marni on the Move partners, sponsors, and guests SUPPORT THE PODCAST Leave us a review on Apple. It's easy, scroll through the episode list on your podcast app, click on five stars, click on leave a review, and share what you love about the conversations you're listening to. Tell your friends to what you love on social. Screenshot or share directly from our stories the episode you're listening to, tag us and the guests, and use our new Marni on the Move Giphy! SPECIAL THANKS Emma Steiner for help with show notes, guest research, and social media. Skye Menna for help with guest research and outreach, social media, and public relations      

Hundertausende Patienten sind zurzeit auf Transplantationslisten und warten auf lebenswichtige Organe, wie Nieren, Herzen und Lebern, die lebensrettend sein könnten. Leider gibt es nicht annähernd genügend Spenderorgane, um die Nachfrage zu bedienen. Was wäre, wenn wir anstatt warten zu müssen, ganz neue, maßgeschneiderte Organe aus dem Nichts herstellen können? Diese Idee, verbirgt sich hinter 3D Bioprinting. Show Notes 146 – Aurelian Briner – CEO von der SNAQ – eine Mahlzeitenerkennungs App 211 – meala App – Lerne aus Deinen und den Erfahrungen anderer Chimära ** Danke für´s Zuhören **   Besuche mich auch auf Instagram: @Zuckerjunkies   *** NEU FB-Gruppe: https://Zuckerjunkies.com/facebook   ** kostenloses eBook über Fett-Protein-Einheiten – ** ►► https://zuckerjunkies.com/produkte/  

A dog in the Siberian city of Novosibirsk has been fitted with a full set of prosthetic titanium limbs, made using a 3D printer. - Собаке в Новосибирске установили полный комплект титановых протезов конечностей, изготовленных на 3D-принтере. Ветеринар Сергей Горшков рассказывает, что это уникальный случай.

Well Said has invited Dr. Daniel Grande is the Assistant Vice President of Research Services at the Feinstein Institutes for Medical Research, at Northwell Health. He is also a Professor of Molecular Medicine and Orthopedic Surgery and within the Institute of Bioelectronic Medicine at the Zucker School of Medicine at Hofstra/Northwell and Feinstein Institutes for Medical Research.to talk about 3D bioprinting, a way of creating three-dimensional structures out of living tissue or biological material.

Dr Sam Moxon, narrates his blog written for NIHR Dementia Researcher. Sam introduces us to 3D Bioprinting, and work to print human tissue-like structures in the lab. But could this revolutionise dementia research? And has this revolution already quietly happening in Manchester.  Find the original text, and narration here on our website. https://www.dementiaresearcher.nihr.ac.uk/guest-blog-can-we-3d-print-revolutionary-dementia-research Enjoy listening and reading our blogs? We're always on the look out for new contributors, drop us a line and share your own research and careers advice dementiaresearcher@nihr.ac.uk

#3Dbioprinting #3dprintedskin #biotechnology #organtransplant #nextbiginnovationlab #nbil #innovationlab #trivima #innoskin #futureoforgantransplant Can you imagine zero wait times for an organ transplant? This may soon be possible, thanks to the work being done by the pioneering biotech company, Next Big Innovation Labs. It is making exceptional use of disruptive 3D Bioprinting technology to revolutionize pharmaceutical, clinical and cosmetic Research and Development. Piyush Padmanabhan is the Co-Ceo/Co-Founder at the Next Big Innovations Labs a startup of enthusiastic individuals on a mission to confront the world's most challenging problems in the healthcare space.NBIL is a research-driven startup working on a novel approach to tackle the current muddle vexing the pharmaceutical, clinical and cosmetic R&D sectors. NBIL focuses on solving the organ availability crisis plaguing the entire globe using 3D Bioprinting; aiming to create a world where the abyss between organ demand and availability for organ transplantation is bridged by in-vitro organogenesis. NBIL's proprietary printer, Trivima, India's first customizable 3D Bioprinter is set to transform many traditional areas of medical research and practice, like bone regeneration, wound healing and new material development. Innoskin is NBIL's 3D Bioprinted Human skin, complete with the intricate architecture, that is developed using the patient's own cells to treat wounds, burns, and other skin-related injuries and cosmetic corrections. Next Big Learning is their foundation course on 3D bioprinting https://nextbiglab.com/ https://nextbiglab.com/nextbiglearning-courseon3dbioprinting/ https://in.linkedin.com/in/piyush-padmanabhan-6817b130

Imagine being able to eliminate the waiting list for organ transplants by creating patient-specific organs through biomaterials. Or replacing animal testing altogether through improved tissue models. That's the power of 3D bioprinting, which could entirely revolutionize the healthcare industry.  Before we introduce today's guest, check out our MSE-themed merchandise if you want to support us or simply show off your love of materials science! Today's guest is Dr. Itedale Namro Redwan, the Chief Scientific Officer at CELLINK, an industry leader in bioprinter and bioink technologies. In this episode, she discusses a variety of 3D bioprinting applications, bioink properties, and the future of CELLINK and the rest of the industry. In this conversation, we discuss the following topics: Differences between 3D bioprinting and 3D printing What properties are required of bioinks in this space? Development of biomaterials for regenerative medicine Challenges with scaling up to full-sized organ printing Advice for MSEs who'd like to get involved in 3D bioprinting Also, check out our free professional development guide for materials scientists and engineers! Thank you Joao Morgado for editing this episode! Join our Discord community! You can meet other passionate materials scientists and engineers from around the world, discuss the latest breakthroughs in MSE, share materials-related memes, and get career advice from experts in the field. For shorter segments and full video podcasts, subscribe to our channel on YouTube. For bloopers, audiograms, and interesting materials science articles, follow us on Instagram, LinkedIn, and Twitter. Feel free to message us on our social media platforms if you have any feedback or recommendations for future episodes, or email us directly at itsamaterialworldpodcast@gmail.com. Finally, reach out to David Yeh and Punith Upadhya on LinkedIn if you'd like to chat about the latest breakthroughs in MSE! Disclaimer: Any opinions expressed by either guests or hosts in this show are their own, and do not represent the opinions of the companies or organizations for which they are affiliated.

Listen Now Approximately 100,000 Americans are waiting an organ transplant. The vast majority will are awaiting a a kidney -...

As NASA plans to returning astronauts to the Moon and future long-duration exploration missions, additive manufacturing will continue to play a greater role in the future of space. One of additive's most exciting areas is bioprinting of living cells. Indiana-based aerospace company TechShot's Chief Scientist Eugene Boland, who is currently leading the team that manages the 3D Biofabrication facility aboard the International Space Station, discusses the advances and challenges of bioprinting in space.

Rice University bioengineer Jordan Miller and his students cleared a major hurdle on the path to 3D printing replacement organs when they published a breakthrough technique for bioprinting "multivascular" tissues that was featured on the cover of the journal Science in 2019.Their innovation allows scientists to bioprint tissues with exquisitely entangled vascular networks for transporting blood, air, lymph, and other vital fluids. The work included a stunning proof-of-principle demonstration: a hydrogel model of a lung-mimicking air sac that was rhythmically filled and emptied of air, simulating inhalation and exhalation. A basket-like network of blood vessels surrounded the air sac but did not physically touch it. As deoxygenated blood flowed past the air sac, red blood cells became oxygenated from air that diffused from the sac to the nearby blood vessels.Jordan joins us today to talk about these innovative movements forward. Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. - sponsor  BonusHow Your Diet Affects Your Risk for Cancer

Rice University bioengineer Jordan Miller and his students cleared a major hurdle on the path to 3D printing replacement organs when they published a breakthrough technique for bioprinting "multivascular" tissues that was featured on the cover of the journal Science in 2019.Rice University bioengineer Jordan Miller and his students cleared a major hurdle on the path to 3D printing replacement organs when they published a breakthrough technique for bioprinting "multivascular" tissues that was featured on the cover of the journal Science in 2019.Their innovation allows scientists to bioprint tissues with exquisitely entangled vascular networks for transporting blood, air, lymph, and other vital fluids. The work included a stunning proof-of-principle demonstration: a hydrogel model of a lung-mimicking air sac that was rhythmically filled and emptied of air, simulating inhalation and exhalation. A basket-like network of blood vessels surrounded the air sac but did not physically touch it. As deoxygenated blood flowed past the air sac, red blood cells became oxygenated from air that diffused from the sac to the nearby blood vessels.Jordan joins us today to talk about these innovative movements forward. Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. - sponsor  BonusHow Your Diet Affects Your Risk for Cancer

Rice University bioengineer Jordan Miller and his students cleared a major hurdle on the path to 3D printing replacement organs when they published a breakthrough technique for bioprinting "multivascular" tissues that was featured on the cover of the journal Science in 2019.Rice University bioengineer Jordan Miller and his students cleared a major hurdle on the path to 3D printing replacement organs when they published a breakthrough technique for bioprinting "multivascular" tissues that was featured on the cover of the journal Science in 2019.Their innovation allows scientists to bioprint tissues with exquisitely entangled vascular networks for transporting blood, air, lymph, and other vital fluids. The work included a stunning proof-of-principle demonstration: a hydrogel model of a lung-mimicking air sac that was rhythmically filled and emptied of air, simulating inhalation and exhalation. A basket-like network of blood vessels surrounded the air sac but did not physically touch it. As deoxygenated blood flowed past the air sac, red blood cells became oxygenated from air that diffused from the sac to the nearby blood vessels.Jordan joins us today to talk about these innovative movements forward. Want better health and nutrition? Now you can get personalized supplement recommendations and custom vitamin packs delivered to your door! Go to PersonaNutrition.com/Roizen and take your free assessment and get 50% off your order today. - sponsor  BonusHow Your Diet Affects Your Risk for Cancer

Hazem Alkazemi is researching tissue engineering at the University of Melbourne with the aim of one day being able to print human organs. He tells us how far this revolutionary technology has advanced and what it will mean for humanity. - Hazem Alkazemi forscht an der Universität Melbourne in der Gewebetechnik, mit dem Ziel, eines Tages menschliche Organe herzustellen. Er erzählt, wie weit diese revolutionäre Technologie fortgeschritten ist und was sie für die Menschheit bedeuten wird.

Christine Whiteside, COO of VoxCell BioInnovation, discusses 3D bioprinting, including current and future applications and key barriers to realizing its full potential. She also shares her tips for getting new healthcare and biotech startups off the ground, plus much more.Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalChristine Whiteside: https://www.linkedin.com/in/verena-voelter-md-44aa4116/VoxCell BioInnovation: https://www.voxcellbio.com/

This week, host Brian Mac Mahon speaks with Nishit Pancholi, Co-founder, COO, and CMO of Jointechlabs. In this episode, Brian and Nishit talk about how Jointechlabs started, their struggles, and how they overcame them. The mind-blowing technology they have for regenerative medicine explains why you should invest in them. About Jointechlabs: Jointechlabs (JTL) is an emerging worldwide leader in point-of-care regenerative medicine therapies. MiniTC™ - FDA cleared  Mini-Stem System™ - For EU and ROW With their devices and technology, they enable healthcare practitioners (HCPs), and hospitals to provide safe, cost-effective non-surgical regenerative medicine therapies at the point of care without change in the infrastructure. Both MiniTC™ and Mini-Stem System™ are medical devices that can be used as stand-alone or as a platform for the development of clinical therapies and 3D Bioprinting of tissues. For more info, please visit www.jointechlabs.com If you have the next big idea, apply to the Expert Dojo Accelerator: www.expertdojo.com

In this episode, I had the pleasure to chat with professor Stephanie Willerth at the University of Victoria, also the founder of Axolotl Biosciences.Stephanie is not only an expert in bioprinting and bioinks in general, but also one of a few scientists in the world focusing on using 3D cell models on common but devastating neurological diseases such as GBM, Parkinson's Disease, and Alzheimer's Disease. We started with some basic concepts related to bioprinting, bioinks, organoids, and organ-on-a-chip, and some of the general current applications and ongoing researches. All of these technologies, however, require sophisticated bioink formulation to achieve structural and functional goals. Also, who are the major players in commercial bioprinting? Other versions of this episode: WebsiteInstagramAxolotl BiosciencesWillerth LabYoutubePast blog by prof. Willerth: 3D Bioprinting Glioblastoma Models for Drug Screening3D Bioprinting Personalized Brain TissuesAbout Our Guest:Dr. Willerth holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences as an Associate Professor.She serves as the Acting Director for the Centre for Biomedical Research at the University of Victoria and on the steering committee of the B.C. Regenerative Medicine Initiative. She also served as the President of the Canadian Biomaterials Society from 2017-2018. Her honors include being named the 2018 REACH award winner for Excellence in Undergraduate Research-inspired Teaching, a Woman of Innovation in 2017, one of the 2015 Young Innovators in Cellular and Biological Engineering, and a “Star in Global Health” by Grand Challenges Canada in 2014. She spent the Fall of 2016 on sabbatical at the Wisconsin Institute for Discovery supported by the International Collaboration on Repair Discoveries International Travel Award where she wrote her book “Engineering neural tissue using stem cells” published by Academic Press.She completed her postdoctoral work at the University of California-Berkeley after receiving her Ph.D. in Biomedical Engineering from Washington University. Her undergraduate degrees were in Biology and Chemical Engineering from the Massachusetts Institute of Technology.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)

Is it Lebron James? No that is just what episode we are on...........23! The episode begins with a jovial discussion on what to get your dad for Father's Day. Hint you better hurry because it is this weekend. We then spend the majority of the episode taking a deeper than normal dive into bio 3D printing organs. We try to answer the questions of what is it, who made it, and is it ethical? Once the 3D bioprinting segment is over Rainer details his next project, which will help him get back into shape, what could it be? Asher then ends the episode with a light-hearted overdue library story. Trust us do not read too far into it. As always a new brainteaser enters the battle, will you know the answer? Listen to find out :) Thank you, Asher and Rainer This Week's Brainteaser: Listen to find out :) Email for Guesses: Thebuildplatepodcast@gmail.com Rad - Maker - Bro's Etsy: RADMAKERBRO on Etsy --- Support this podcast: https://anchor.fm/thebuildplatepodcast/support

Special discussion with the National Institutes of Health (NIH)'s National Center for Advancing Translational Sciences (NCATS) on 3D Bioprinting during the American Association for Cancer Research (AACR) Virtual Meeting Week 1. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm. Featuring Mr. Sam Michael, Chief Information Officer and Director, Automation and Compound Management at the National Center for Advancing Translational Sciences (NCATS) and Dr. Marc Ferrer, Director of NCATS' intramural 3-D Tissue Bioprinting Laboratory. The NIH is the largest public funder of biomedical research in the world, investing about $37 billion annually in medical research and the AACR Annual Meeting highlights the latest discoveries from across the spectrum of innovative cancer science and medicine. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-nih-3d-bioprinting-aacr-2021

The global 3D bioprinting market size is valued at USD 1.4 billion and is expected to expand at a compound annual growth rate of 15.8% from 2021 to 2028. In this episode of HyeTech Minds I'll sit down with Emmanuel Ghandilyan, MD, who built the first 3D bioprinting startup in Armenia Foldink that provides 3D Bioprinting technology to biomedical scientists who are conducting research in tissue engineering and regenerative medicine. Exciting story on how Emmanuel was able to turn his university project into a successful business. While working on his scientific project at Yerevan State Medical University, Emmanuel decided to work with 3d printers and 3d printing in medicine. After finding out that bio printers and other novel technologies are unavailable in Armenia, Emmanuel joined his efforts with industry experts and otehr scientists to launch the very FIRST 3Dbioprinting company in Armenia FoldInk. During our conversation, Emmanuel shares his success story and gives actionable tips on how to turn scientific language into a successful business. Emmanuel's bio: Emmanuel is a CEO & Co-Founder of Foldink 3D Bioprinting. He is a TEDx Speaker and 3D bioprinting/3D printing expert, entrepreneur, bioengineer and MD physician working on applying additive manufacturing technologies in biomedical science and medicine. -------------------------------------------- Resources For show notes and past guests, please visit https://hyetechminds.com/ To learn more about FoldInk, please visit https://foldink.am/ To connect with Emmanuel visit his LinkedIn Page Sign up for HyeTech Newsletter For the transcript of this episode, go to https://hyetechminds.com/ Follow us on Twitter @hyetechminds Follow us on Facebook @hyetechminds --- Send in a voice message: https://podcasters.spotify.com/pod/show/hyetechminds/message

The National Science Foundation is setting free 50x (out of 4000) ocean drifting biogeochemical sensors to monitor the oceans health - Article Link Here. The Hydrogen Energy Supply Chain will provide enough power for all of Japan for the entire country to be carbon-neutral by 2050 - Article Link Here. Labs has successfully bio-printed personalized parts of the human heart, liver, and more - Article Link Here.Follow the STEMnews Podcast on Twitter or LinkedIn. Feel free to send an email at stemnewspodcast@gmail.com with any questions, feedback, recommendations, or ideas for future topics to discuss.

A Christchurch researcher is developing technology he hopes can print human blood vessels and tissue.Biomedical engineer, Dr Khoon Lim, has been researching the technology for the past eight years and has pioneered a "bio ink" containing human cells.He told Chris Lynch he is trying to create functional body parts that can be implanted into patients.Dr Lim now has prototypes of printed human cartilage.Listen above.

Schön, dass du wieder eingeschaltet hast bei unserem Podcast Finanzen.Parkett. Jeden Tag warten unzählige Menschen in Deutschland, aber auch woanders auf dieser Welt auf ein Spenderorgan. In Deutschland sind es 10.000 Menschen täglich und in den USA sogar mehr als 113.000 Menschen im Jahre 2019, die unbedingt ein neues Organ implantiert haben müssen. Das U.S. - Gesundheitsministerium ist somit der Auffassung, dass jeden Tag in den USA 20 Menschen ums Leben kommen, weil es keinen Organspender gibt oder das Organ dem Patienten nicht rechtzeitig zur Implantation zur Verfügung gestellt wird. Wird daher das 3D-Bioprinting für uns Menschen immer wichtiger werden und ist es die Lösung in naher Zukunft, damit noch viel mehr Menschenleben gerettet werden können? Das klingt jetzt wahrscheinlich sehr sarkastisch, aber sollten wir uns 3D gedruckte Organe nicht auf Vorrat legen? In dieser Podcastfolge klären wir auf was es mit dem 3D-Druck bzw. Bioprinting auf sich hat, wie es dazu kam (Geschichte), was es in der Zukunft für Möglichkeiten gibt und welche 3D-Druckverfahren derzeit verwendet werden. (Inkjet-Biodruck, Extrusions-Biodruck, Biodruck mit Lasern, Stereolithografie, Druck durch akustische Wellen und SWIFT-Technik) Zum Schluss stellen wir euch noch kurz ein paar Unternehmen vor, die sich bereits auf das Drucken von Organen, Blutgefäßen etc. spezialisiert haben. Unter anderem folgende: Cellink Organovo United Therapeutics Falls du weiter Informationen möchtest: Jannik: Finanzenfuchs -- https://www.instagram.com/finanzenfuchs/ Gerrit: Parkett.Hirsch -- https://www.instagram.com/parkett.hirsch/ Unser Blog: https://www.finanzenparkett.de Neues Produkt: Finanzen-Check (https://forms.gle/sTFFkRwZ3S7ZZkc27) Danke für deine Aufmerksamkeit und bis zum nächsten Mal, dein Team von Finanzen.Parkett. Empfehlungen: Kryptowährungen handeln über die Bison-App (https://join.bisonapp.com/wcwh7m) (*) (investiere 50€ und erhalte 10€ extra einmalig) Investiere noch heute in Privatkredite (*keine Anlageberatung/ hohes Risiko): Mintos: https://www.mintos.com/de/l/ref/IL0XQS Bondora: https://bondora.com/ref/jannikh Anmerkung: Werbe-/ Affiliate Links: Die mit (*) gekennzeichneten Links sind Affilatelinks. --- Send in a voice message: https://anchor.fm/finanzen-parkett/message

Did you know your bones and muscles are intrinsically connected and in uninterrupted communication to make your body properly function? How about the research on 3D bioprinting (and we'd like to emphasize on bio) to incorporate it into the medical field sooner than you may be imagining? Small changes can lead to a healthier life, and Jello could be the tissue of the future. As weird as the last part of that statement may sound, it is not even that far from the truth. Today's episode is both educational and mind-blowing, as Dr. Rosie Sendher and Dr. Erica Fisk sit down with Dr. Marco Brotto and Dr. Venu Varanasi to chat about the fascinating concept of bone-muscle crosstalk and the no longer futuristic term of bioprinting. Dr. Marco Brotto is a George & Mary Hazel Jay Endowed Professor, Director of the Bone-Muscle Collaborative Sciences, and the Director of the Bone-Muscle Research Center. Dr. Venu Varanasi received his Ph.D. at the University of Florida in the Department of Chemical Engineering and is currently an assistant professor of Biomedical Sciences at Texas A&M University. Resources Bone-Muscle Research Center: https://www.uta.edu/conhi/research/bmrc/index.php This show is being produced by StudioPod, a full-service podcast company based in San Francisco. If you want more details on how to fully record and produce your podcast with our services, you can reach us at http://studiopodsf.com (http://studiopodsf.com), send us an email at info@studiopodsf.com or contact us through our social media channels as @studiopodsf.

A fun but insightful conversation during 3DHEALS2020 with two inspiring entrepreneurs in 3D Bioprinting space, Tamer Mohamed (CEO and co-founder of Aspect Biosystems), and Mike Graffeo (CEO and co-founder of Fluidform). Aspect bio has just successfully completed its series A round, and Fluidform just successfully raised its seed round. Learn from Tamer and Mike on what startup CEOs' challenges, experiences, visions, and advice for the biofabrication and 3D printing space. Full conference video recording can be purchased here. Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)

In this episode of Start Up the Science we talk with Erik Gatenholm, CEO and Co-Founder of CELLINK.  CELLINK designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications that span industries, from pharmaceutical to cosmetic. Their patent-pending bioink is a biomaterial innovation that allows human cells to grow and thrive as they would in their natural environment. Researchers leverage CELLINK's technologies to print liver, cartilage, skin tissues and more.  You may have heard or seen CELLINK on the news or on social media and that's because they are changing the future of medicine. They began just 5 years ago and they have grown so quickly in that time. To learn more about CELLINK, visit their website at cellink.com or their Company's LinkedIn Page.  Alternatively, you could email us at info@inam.berlin and we will gladly put you in touch with Erik personally. LISTEN NOW: iTunes Soundcloud Spotify Google Play For questions or comments, please email us at info@inam.berlin. Also, if you or someone you know would like to be a guest on our show, we welcome any and all suggestions!   Special thanks to Oxygen Sound Studios Music: Drops of H2O ( The Filtered Water Treatment ) by J.Lang (c) copyright 2012 Licensed under a Creative Commons Attribution (3.0) license. Ft: Airtone

If you could 3D print a new body part, what would it be? For marine scientist Pia Winberg that question was about to become intensely real. The science and the ethics of a wild frontier for medicine.

If you could 3D print a new body part, what would it be? For marine scientist Pia Winberg that question was about to become intensely real. The science and the ethics of a wild frontier for medicine.

We've asked graduate student Rachel Smith to explain what bioprinting is, and what biohybrid materials are, and give us some idea of where these fields of study are going. 3D printing is everywhere. From bike parts, to fashion, to novelty key chains, to tools and light fixtures. We often see it employed to accelerate production processes and prototyping but what about the biological potential of printing? Audio Explainer transcript: http://news.mit.edu/2020/audio-explainer-bioprinting-biohybrid-materials-0123

What is tissue engineering, can all tissue be engineered and what’s in a bioink?In this episode of Science on surfaces - a bigger perspective on the small we talk to Prof. Paul Gatenholm, Division of Chemistry and Chemical Engineering at Chalmers University of technology and Director of 3D Bioprinting Center, BBV at Biotech Center. In the studio, we also have Prof. Bengt Kasemo, Chalmers University of technology, who has long experience in the area of biomaterials.We start with the basics and Paul tells us more about what tissue engineering is, how it works and what the engineered tissue can be used for. We also talk about where surfaces come into play, what challenges there are in terms of growing and using the tissue, and how vascularized organ tissue in the future could be sent into space to learn more about what negative effects deep space mission would have on humans.If you are interested in surface science and related topics, you should also check out our Surface Science blog!

How can we use 3D bioprinting technology to save millions of lives? Hear what Erik Gatenholm, CEO & Co-Founder at CELLINK has to say. 2,465 people die everyday waiting for a transplant. Erik Gatenholm has founded the biotech company that has developed the world’s first universal bioink; making 3D printing organs affordable and scalable. If you would like to donate, volunteer, or learn more, visit https://bit.ly/2rTQmXt If you enjoyed our episode please make sure to subscribe and leave us a review. If you want to nominate a social impact leader who is finding scalable sustainable solutions for world pressing problems, please reach out to us at guest@gettingtherepodcast.com To access more stories, blog posts, videos, quizzes (and more!), highlighting leaders tackling humanity's biggest problems, follow us on: LinkedIn | Medium | Website | Facebook | Instagram --- Send in a voice message: https://anchor.fm/gettingtherepodcast1/message

In episode 12, we spent time with an internationally recognized entrepreneur, engineer and inventor. Michael Golway is the President and CEO of Advanced Solutions Life Sciences and has dedicated his company to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology. In short, Michael and his team are helping lead the global 3D bioprinting revolution through proprietary, cutting-edge and innovative technology that is turning this new and nascent industry into reality. During this episode, Michael shared his history as an entrepreneur and some of the terrifying moments of building companies from scratch, and how his almost ten year old company and bioprinting platform is perfectly positioned to empower scientists and innovators around the world to uncover new discoveries in their pursuits to bring a new health paradigm to the human race. While listening to any of our episodes, please share feedback and ideas for our guest via our guest feedback form link and nominate other passionate pioneers for a future episode via our guest nomination form link. Lastly- please take a moment to subscribe to the podcast so you will automatically receive episode updates in your podcast player. I want to thank Michael and his team for their relentless pursuit and passion to unlock the mysteries of the human body and to discover new ways to bring physical health to so many people around the world. In personally knowing Michael, I have no doubt he will achieve his mission he discusses during the episode. I hope you join Michael and his team during their pioneering journey for mankind! While listening to any of our episodes, please make sure to join our online community at passionatepioneers.com in order to share feedback and ideas with our guests and to interact with the global community. Lastly- please subscribe to the podcast so you will automatically receive episode updates in your podcast player. Simply search Passionate Pioneers with Mike Biselli in iTunes or Spotify, or wherever you listen to your podcasts. Support this podcast

There are roughly 120,000 people in the United States on waiting lists for live-saving organ transplants, with only about 30,000 transplants happening every year. To address this great challenge of organ shortages, a team at the Wyss Institute led by Core Faculty member Jennifer Lewis, Sc.D., is developing a method for 3D bioprinting organ tissues with requisite vasculature for eventual organ transplant. In this episode of Disruptive, Jennifer Lewis is joined by Wyss Institute Research Associate Mark Skylar-Scott, Ph.D., and former Wyss Institute Postdoctoral Fellow Kimberly Homan, Ph.D., to talk about the current status of their work, challenges they face, and the next steps in their path to 3D bioprint human organs.

Wollongong, south of Sydney, is famous for beaches, rainforests and increasingly its world-leading 3D bioprinting facility, TRICEP. In this episode of the MTPConnect podcast series, we tour TRICEP, speak with its Director Professor Gordon Wallace and Dr Stephen Beirne and delve into the world of cellular engineering and bioprinting.

In this episode of the PRS Global Open Keynotes Podcast, Swedish plastic surgeon Paul Gattenholm, MD discusses skin grafting in 3D bioprinted cartilage with your host, Australian plastic surgeon Damian Marucci, MD. The PRS Global Open article discussed is available to read for free on PRSGlobalOpen.com: “Skin grafting on 3D bioprinted cartilage constructs in vivo” by Peter Apelgren, Matteo Amoroso, Paul Gattenholm et al. Read Here: http://bit.ly/GrowinganEar Special guest Paul Gattenholm MD, is a plastic surgeon at the 3D Bioprinting Center at the Chalmers University of Technology, Goteborg, Sweden. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery

In this episode of the PRS Global Open Keynotes Podcast, Swedish plastic surgeon Paul Gatenholm, MD discusses skin grafting in 3D bioprinted cartilage with your host, Australian plastic surgeon Damian Marucci, MD. The PRS Global Open article discussed is available to read for free on PRSGlobalOpen.com: "Skin grafting on 3D bioprinted cartilage constructs in vivo" by Peter Apelgren, Matteo Amoroso, Paul Gatenholm et al. Read Here: http://bit.ly/GrowinganEar Special guest Paul Gatenholm MD, is a plastic surgeon at the 3D Bioprinting Center at the Chalmers University of Technology, Goteborg, Sweden. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery

A silicon chip with 4 million microscopic mirrors is used to shine UV light in a 3D pattern based on a digital MRI image of the spinal cord wound in rats. The light falls onto a mixture of poly(ethylene) glycol and gelatin methacrylate, which solidifies into the shape of the wound. TranscriptPRACHI PATEL: Welcome to MRS Bulletin’s Materials News Podcast, providing breakthrough news & interviews with researchers on the hot topics of 3D bioprinting, artificial intelligence and machine learning, bioelectronics, perovskites, quantum materials, robotics, and synthetic biology. My name is Prachi Patel.Over 250,000 people around the world suffer a spinal cord injury every year. SHAOCHEN CHEN: Spinal cord damage turns out to be a very devastating disease. You know people cannot walk, they feel nothing below the hip and other parts of the body. PATEL: Shaochen Chen, a nanoengineer at the University of California in San Diego, worked with neuroscientists to 3D-print implants that can repair spinal cord injuries in rats. The implants are customized to fit the injury. The printer uses a silicon chip with four million microscopic mirrors to shine UV light in a three-dimensional pattern based on a digital MRI image of the wound. The light falls onto a mixture of poly(ethylene) glycol and gelatin methacrylate, which solidifies into the shape of the wound. The method is thousands of times faster than conventional 3D-printing techniques, which makes structures one drop or one layer at a time.CHEN: So you can imagine we have about 4 million of these traditional printers doing the same work. And the speed is totally different. We can print the similar sized part in a matter of seconds versus 3 or 4 or 6 hours.PATEL: Chen says the material and the structure of the implant make it unique. Neurons will usually grow around or turn away from foreign materials. But the hydrogel-gelatin combination attracts the cells. The implants have a solid supportive center surrounded by microchannels that are 200 micrometers in diameter. The researchers fill these channels with neural stem cells that urge neurons to grow.CHEN: So if you put this implant in the gap of the damaged site of the spinal cord you hope, you know, that neurons can grow from both ends, they’d reconnect with the help of this kind of implant just like a bridge.PATEL: That’s indeed what happened in rats with spinal cord injuries. The animals had no feeling or movement in their legs, but 11 weeks after getting the implants, they could feel their toes and move their knees. When the researchers removed the implants they saw that neurons had grown through the channels. The team is now moving on to test on monkeys. And Chen is doing a lot more with the 3D-printing method. CHEN: We have been using this technique to print heart tissues, liver tissues, and brain tissue, and also cancer tissue models.PATEL: Pharmaceutical companies could use those printed human tissues for drug testing, which could drastically cut the time and cost of drug development.CHEN: They don’t need to wait until, you know, 10 years to see if this compound or this drug is toxic to the heart or liver in a human setting. And, of course, the long-term goal is to have therapeutical uses of this 3D-printed tissue because they can repair, regenerate damaged tissue, for instance heart wall, for instance piece of liver due to cancer you can cut it out and put this 3D-printed liver piece to fix it.PATEL: The research was published recently in the journal Nature Medicine. My name is Prachi Patel from the Materials Research Society.For more news, log onto the MRS Bulletin website at mrsbulletin.org and follow us on twitter, @MRSBulletin.

Guest: Dr. Stephanie Willerth is an Associate Professor and Canada Research Chair at the University of Victoria. Her research focuses on using engineering-based approaches to stem cell biology. Her team develops bioactive scaffolds for directing…

Юсеф Джоржевич Хесуани, управляющий партнер компании 3D Bioprinting solutions рассказывает о биопечати, её методах и основных проблемах. Беседа вышла достаточно объемной, поэтому было решено разделить её на две части.

In this edition of the I'm Black, He's Mexican Podcast, Arizona Verse & Soul Papo join forces to wax philosophically about Tekashi 6ix9ine being the hottest rapper out, Fabolous attacks Emily B, R Kelly groomed 14-year-old girl as sex 'pet, Roseanne Barr makes sure to promote Trump on sitcom reboot, Wendy's Mixtape We Beefin? ethers the competition, Jaden Smith Syre album is a must listen, Storytime with Verse & Papo: the case of the workplace lunch theft, March for Our Lives Rally, Ted Nugent says Parkland survivors have no soul, Samsung launches a site that can "Erase Your Memory" with hypnosis, 3D-Bioprinting wants to bring every dead person back to life, Florida Man still on the loose, self driving Uber kills someone in Arizona and of course.. dedications. If you don't like this podcast, it's probably because you're racist... #IBHMPodcast Subscribe to the show: on iTunes: https://itunes.apple.com/us/podcast/im-black-hes-mexican-podcast/id692728763 on Soundcloud: https://soundcloud.com/ibhmpodcast on Stitcher: http://www.stitcher.com/s?fid=38104&refid=stpr on Tune-In Radio: http://tunein.com/radio/Im-Black-Hes-Mexican-Podcast-p547515/ Catch Us Online: www.ibhmpodcast.com Email Us: ibhmpodcast@gmail.com

Co-founder and CEO of BioBots, Danny Cabrera, joins us to talk about the technology and advancements in 3D bioprinting and the future of this fascinating industry. BioBots is building tools to design and engineer life. Their goals are to cure disease, eliminate the organ waiting list, reverse climate change, and live on other planets. Their first products are 3D bioprinters, software, and bioinks that print 3D living tissues one layer at a time. Listen, subscribe, and review Future Tech Podcast. Contribute Bitcoin to fuel our interviews and keep us going!

3DBio is researching and bringing to market bio printing technologies for the generation and transplantation of tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures. Yousef Hesuani, co-founder of 3DBio, explains how bio printing is becoming a viable opportunity to generate patient-specific tissue for the development of accurate, targeted and completely personalized treatments. Yousef shared an experiment where they successfully transplanted a 3D Printed thyroid into mice that performed well and kept the mice functioning for weeks of time! Bioprinting is a fascinating technology poised to transform the whole medical industry and this interview is a must listen. Listen, review, subscribe… and while you're at it, donate bitcoin to Future Tech Podcast to keep our roster of upcoming guests flowing and our listener base growing! [public key listed on our website]

In 1984, Charles Hull patented a process he called “stereolithography.” Now called three-dimensional (3D) printing, this technology has been used to manufacture rocket engines, custom-fit athletic shoes, and other 3D printers. The medical field also has reaped the benefits of 3D printing. Imaging data from computed tomography (CT) scans, ultrasounds, or magnetic resonance imaging (MRI) can produce 3D images on a computer, and precise 3D-printed anatomical models can be used for teaching or to help in surgical planning.

Organovo's printers create human tissue that mimic the form and function of native tissue in the body — but live outside the body. This is a big deal. A feat of science and engineering that's truly disruptive, sci-fi kind of stuff. But the innovation alone doesn't guarantee success. Once you've created something truly novel, how do you bring it to market? As any technology or life sciences CMO will appreciate, marketing an innovation that outstrips what people know how to applyin their lives is hard work. In this episode of The Uncoventionals, we talk with Organovo CEO Keith Murphy about bioprinting and its big implications for human health. We'll also discuss how they tell their story, find early application markets, and convince pharma customers to try the platform. Turns out that WHO you talk to first is critical. The key is connecting with buyers that are, as Keith says, “alive to new possibilities.” Find out how Organovo is enlisting the change agents — or as we like to call them "the crazies” — to bring a breakthrough platform to life. 

Special guest David Kretzman talks CES highlights and fitting healthcare into a portfolio. See supernovaradio.fool.com for more!

Can we 3D print new organs? How do lasers turn deadly bacteria into X-ray machines? How does the real science stack up against the pseudo-scientific fad 'pH' balanced diets? Check out this week's Lagrange Point!